Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
P 2 (1)

Trial Status

Not Yet Recruiting3
Recruiting1
Enrolling By Invitation1

Clinical Trials (5)

Showing 5 of 5 trials
NCT07284576Phase 2Enrolling By Invitation

Ultralow Dose PET Imaging of 18F-flurpiridaz

NCT07407738Not ApplicableNot Yet RecruitingPrimary

ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions

NCT07388745Not ApplicableNot Yet RecruitingPrimary

ESPB vs SPSIP for Postoperative Analgesia After CABG

NCT07293858RecruitingPrimary

Optical Coherence Tomography: Prognostic Value and Artificial Intelligence

NCT07109479Not ApplicableNot Yet RecruitingPrimary

Safety and Effectiveness of the Single-Use Coronary Forward Intravascular Lithotripsy Catheter Combined With the Intravascular Lithotripsy Therapy Device

Showing all 5 trials

Research Network

Activity Timeline